| Attribute |
Value |
| 52 Week Change |
-0.4352941 |
| Address1 |
19,805 North Creek Parkway |
| All Time High |
1,440.0 |
| All Time Low |
0.86 |
| Ask |
1.27 |
| Ask Size |
2 |
| Average Daily Volume10 Day |
27,150 |
| Average Daily Volume3 Month |
121,421 |
| Average Volume |
121,421 |
| Average Volume10Days |
27,150 |
| Beta |
1.407 |
| Bid |
0.72 |
| Bid Size |
2 |
| Book Value |
0.299 |
| City |
Bothell |
| Compensation As Of Epoch Date |
1,767,139,200 |
| Country |
United States |
| Crypto Tradeable |
0 |
| Currency |
USD |
| Current Price |
0.96 |
| Current Ratio |
2.664 |
| Custom Price Alert Confidence |
HIGH |
| Date Short Interest |
1,782,777,600 |
| Day High |
1.01 |
| Day Low |
0.96 |
| Debt To Equity |
34.597 |
| Display Name |
Cocrystal Pharma |
| Dividend Date |
1,516,752,000 |
| Earnings Timestamp End |
1,755,084,600 |
| Earnings Timestamp Start |
1,755,084,600 |
| Ebitda |
-8,975,000 |
| Ebitda Margins |
0.0 |
| Enterprise To Ebitda |
-1.111 |
| Enterprise To Revenue |
44.333 |
| Enterprise Value |
9,974,955 |
| Eps Current Year |
-0.685 |
| Eps Forward |
-0.64 |
| Eps Trailing Twelve Months |
-0.72 |
| Esg Populated |
0 |
| Exchange |
NCM |
| Exchange Data Delayed By |
0 |
| Exchange Timezone Name |
America/New_York |
| Exchange Timezone Short Name |
EDT |
| Fifty Day Average |
1.1162 |
| Fifty Day Average Change |
-0.15619999 |
| Fifty Day Average Change Percent |
-0.13993907 |
| Fifty Two Week Change Percent |
-43.529408 |
| Fifty Two Week High |
2.67 |
| Fifty Two Week High Change |
-1.71 |
| Fifty Two Week High Change Percent |
-0.6404494 |
| Fifty Two Week Low |
0.86 |
| Fifty Two Week Low Change |
0.099999964 |
| Fifty Two Week Low Change Percent |
0.11627903 |
| Fifty Two Week Range |
0.86 - 2.67 |
| Financial Currency |
USD |
| First Trade Date Milliseconds |
1,329,921,000,000 |
| Float Shares |
9,124,950 |
| Forward Eps |
-0.64 |
| Forward P E |
-1.5 |
| Free Cashflow |
-4,412,250 |
| Full Exchange Name |
NasdaqCM |
| Full Time Employees |
10 |
| Gmt Off Set Milliseconds |
-14,400,000 |
| Gross Margins |
0.0 |
| Gross Profits |
-4,841,000 |
| Has Pre Post Market Data |
1 |
| Held Percent Insiders |
0.30725 |
| Held Percent Institutions |
0.05631 |
| Implied Shares Outstanding |
13,787,453 |
| Industry |
Biotechnology |
| Industry Disp |
Biotechnology |
| Industry Key |
biotechnology |
| Is Earnings Date Estimate |
1 |
| Language |
en-US |
| Last Fiscal Year End |
1,767,139,200 |
| Last Split Date |
1,665,446,400 |
| Last Split Factor |
1:12 |
| Long Business Summary |
Cocrystal Pharma, Inc., a biotechnology company, focuses on the discovery and development of antiviral therapeutic treatments for serious and/or chronic viral diseases in the United States. The company employs structure-based technologies to create antiviral drugs including influenza virus, norovirus, coronaviruses, such as SARS-CoV-2 and MERS-CoV, as well as respiratory virus infections, and hepatitis C virus (HCV) infections. The company develops CC-42344, a novel PB2 inhibitor, which is in phase 2a clinical trial, as a potential treatment for pandemic and seasonal influenza A; and the inhaled CC-42344 for the potential prophylactic treatment of pandemic and seasonal influenza infections. It is also developing CDI-988, an oral pan-viral, which is a phase 1 clinical trial to treat noroviruses and coronaviruses, including SARS-CoV-2 and its variants; and CC-31244, an HCV non-nucleoside inhibitor that has completed Phase 2a clinical trial to treat HCV. The company has a license and research collaboration agreement with Merck Sharp & Dohme Corp. to discover and develop proprietary influenza A/B antiviral agents; and a license agreement with Kansas State University Research Foundation to develop antiviral compounds for the treatment of norovirus and coronavirus infections. Cocrystal Pharma, Inc. was headquartered in Bothell, Washington. |
| Long Name |
Cocrystal Pharma, Inc. |
| Market |
us_market |
| Market Cap |
13,235,955 |
| Market State |
PRE |
| Max Age |
86,400 |
| Message Board Id |
finmb_49062639 |
| Most Recent Quarter |
1,774,915,200 |
| Net Income To Common |
-8,829,000 |
| Next Fiscal Year End |
1,798,675,200 |
| Non Diluted Market Cap |
13,235,954 |
| Number Of Analyst Opinions |
2 |
| Open |
1.01 |
| Operating Cashflow |
-7,593,000 |
| Operating Margins |
-10.471109 |
| Payout Ratio |
0.0 |
| Phone |
877 262 7123 |
| Previous Close |
1.01 |
| Price Eps Current Year |
-1.4014598 |
| Price Hint |
4 |
| Price To Book |
3.2107024 |
| Price To Sales Trailing12 Months |
58.826466 |
| Profit Margins |
0.0 |
| Quick Ratio |
2.443 |
| Quote Source Name |
Nasdaq Real Time Price |
| Quote Type |
EQUITY |
| Recommendation Key |
none |
| Region |
US |
| Regular Market Change |
-0.05 |
| Regular Market Change Percent |
-4.9505 |
| Regular Market Day High |
1.01 |
| Regular Market Day Low |
0.96 |
| Regular Market Day Range |
0.96 - 1.01 |
| Regular Market Open |
1.01 |
| Regular Market Previous Close |
1.01 |
| Regular Market Price |
0.96 |
| Regular Market Time |
1,783,972,801 |
| Regular Market Volume |
27,146 |
| Return On Assets |
-0.62441003 |
| Return On Equity |
-1.54623 |
| Revenue Per Share |
0.018 |
| Sand P52 Week Change |
0.20365608 |
| Sector |
Healthcare |
| Sector Disp |
Healthcare |
| Sector Key |
healthcare |
| Shares Outstanding |
13,787,453 |
| Shares Percent Shares Out |
0.0293 |
| Shares Short |
404,505 |
| Shares Short Previous Month Date |
1,780,012,800 |
| Shares Short Prior Month |
143,168 |
| Short Name |
Cocrystal Pharma, Inc. |
| Short Percent Of Float |
0.039100002 |
| Short Ratio |
4.01 |
| Source Interval |
15 |
| State |
WA |
| Symbol |
COCP |
| Target High Price |
10.0 |
| Target Low Price |
8.0 |
| Target Mean Price |
9.0 |
| Target Median Price |
9.0 |
| Total Cash |
4,685,000 |
| Total Cash Per Share |
0.34 |
| Total Debt |
1,424,000 |
| Total Revenue |
225,000 |
| Tradeable |
0 |
| Trailing Annual Dividend Rate |
0.0 |
| Trailing Annual Dividend Yield |
0.0 |
| Trailing Eps |
-0.72 |
| Trailing Peg Ratio |
None |
| Triggerable |
1 |
| Two Hundred Day Average |
1.1067 |
| Two Hundred Day Average Change |
-0.14669997 |
| Two Hundred Day Average Change Percent |
-0.13255623 |
| Type Disp |
Equity |
| Volume |
27,146 |
| Website |
https://www.cocrystalpharma.com |
| Zip |
98,011 |